Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...

Along with these studies, the NCCN also recommends additional serum and urine analyses. The serum is analyzed to determine immunoglobulin levels, how much monoclonal protein is present (through ...

the National Comprehensive Cancer Network (NCCN) guidelines for treating multiple myeloma recommend Pomalyst as a treatment option in adults with multiple myeloma who meet the above criteria.

Sarclisa was added to the National Comprehensive Cancer Network (NCCN) guidelines for non-transplant multiple myeloma candidates as a category 1 (preferred) option alongside VRd and Darzalex plus ...

Callander, MD, director of the University of Wisconsin Carbone Cancer Center Myeloma Clinical Program, reviewed the treatment landscape at the National Comprehensive Cancer Network (NCCN ...